US Oncology Reports Fourth Quarter and Fiscal Year 20...((loss) before income taxes ...)

Income tax benefit (provision) 17,447 (18,926)

Net income (loss) $(34,973) $26,158

US ONCOLOGY HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(in thousands)

Year Ended

December 31,

2007 2006

Cash flows from operating activities:

Net cash provided by operating activities $164,677 $20,517

Cash flows from investing activities:

Proceeds from sale of property and equipment 750 9,261

Acquisition of property and equipment (90,850) (82,571)

Acquisition of business, net of cash acquired - (31,378)

Investment in subsidiaries (4,745) (2,450)

Payments in practice affiliation transactions (134) (3,630)

Distributions from minority interests 254 -

Proceeds from contract separation 1,555 -

Net cash used in investing activities (93,170) (110,768)

Cash flows from financing activities:

Proceeds from senior floating rate PIK toggle notes,

net of issue costs 413,232 -

Proceeds from term loan - 100,000

Proceeds from other indebtedness 1,323 4,522

Repayment of senior floating rate notes (256,766) -

Repayment of term loan (7,487) (1,000)

Repayment of other indebtedness
'/>"/>